Temporal changes of soluble ST2 after cardiovascular interventions.
about
The emerging role of Galectin-3 and ST2 in heart failure: practical considerations and pitfalls using novel biomarkers.Increased Plasma Concentrations of Soluble ST2 Independently Predict Mortality but not Cardiovascular Events in Stable Coronary Heart Disease Patients: 13-Year Follow-up of the KAROLA Study.Undiagnosed airflow limitation is common in patients with coronary artery disease and associated with cardiac stress.Clinical roles of soluble ST2 for the outcomes of cardiac valve operationsA meta-analysis of soluble suppression of tumorigenicity 2 (sST2) and clinical outcomes in pulmonary hypertension.
P2860
Temporal changes of soluble ST2 after cardiovascular interventions.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Temporal changes of soluble ST2 after cardiovascular interventions.
@en
Temporal changes of soluble ST2 after cardiovascular interventions.
@nl
type
label
Temporal changes of soluble ST2 after cardiovascular interventions.
@en
Temporal changes of soluble ST2 after cardiovascular interventions.
@nl
prefLabel
Temporal changes of soluble ST2 after cardiovascular interventions.
@en
Temporal changes of soluble ST2 after cardiovascular interventions.
@nl
P2093
P2860
P50
P356
P1476
Temporal changes of soluble ST2 after cardiovascular interventions.
@en
P2093
Dik Versteeg
Dominique P V de Kleijn
Imo E Hoefer
Jan-Willem Sels
Sanne Willems
Wolfgang F Buhre
P2860
P304
P356
10.1111/ECI.12022
P577
2012-12-06T00:00:00Z